GlassScriptPhysician profile
David P Adkison
NPI 1396743779
$45,648.43
in general payments reported to CMS, 2019-2025
14 companies · $8,423 in 2025
The $8,423 reported for 2025 was more than what 86% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,088 · 2021: $1,193 · 2022: $3,688 · 2023: $11K · 2024: $19K · 2025: $8,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $6,181 · Food and Beverage: $1,952 · Royalty Or License: $1,473 · Gift: $74.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,000.00 |
| Travel and Lodging | $6,180.61 |
| Food and Beverage | $1,952.14 |
| Royalty Or License | $1,473.10 |
| Gift | $74.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $35,802.25 | 2019-2025 | Reunion, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Shoulder Innovations, INC. | $9,386.79 | 2024-2025 | Inset System |
| Smith+Nephew, INC. | $158.30 | 2019-2023 | Redapt, Real Intelligence |
| Zimmer Biomet Holdings, INC. | $100.00 | 2022 | |
| Spr Therapeutics, INC | $31.20 | 2024 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $29.20 | 2023 | Exparel, Zilretta, Iovera |
| Baudax Bio INC. | $24.65 | 2021 | |
| Depuy Synthes Sales INC. | $21.70 | 2023 | Orthovisc, Monovisc |
| Conmed Corporation | $17.78 | 2023 | Abc Handpieces, System 2450, Visiclear |
| Nuvasive, INC. | $17.33 | 2019 | |
| Ethicon US, LLC | $17.31 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.39 | 2022 | |
| Vericel Corporation | $13.53 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Adkison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.